---
title: "Fluvoxamine: a $4 Antidepressant That Reduces COVID 19 Hospitalizations"
image: "https:\/\/i.ytimg.com\/vi\/gPqoFFJAaDY\/hqdefault.jpg"
vid_id: "gPqoFFJAaDY"
categories: "Education"
tags: ["fluvoxamine","fluvoxamine side effects","fluvoxamine maleate"]
date: "2021-11-02T08:05:29+03:00"
vid_date: "2021-11-01T20:41:43Z"
duration: "PT22M38S"
viewcount: "25860"
likeCount: "1528"
dislikeCount: "26"
channel: "MedCram - Medical Lectures Explained CLEARLY"
---
{% raw %}Roger Seheult, MD of MedCram on how Fluvoxamine, an inexpensive SSRI medication FDA approved in 1994, was shown to reduce COVID 19 hospitalizations and deaths in a recent randomized placebo controlled trial published in the Lancet. Fluvoxamine (Luvox) was also compared to other medications such as ivermectin, metformin, and hydroxychloroquine in the trial.<br /><br />Roger Seheult, MD is the co-founder and lead professor at <a rel="nofollow" target="blank" href="https://www.medcram.com">https://www.medcram.com</a><br />He is Board Certified in Internal Medicine, Pulmonary Disease, Critical Care, and Sleep Medicine and an Associate Professor at the University of California, Riverside School of Medicine.<br /><br />(This video was recorded on November 1, 2021)<br /><br />LINKS / REFERENCES:<br /><br />Fluvoxamine in the treatment of anxiety disorders (PMC) | <a rel="nofollow" target="blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2424117/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2424117/</a><br /><br />Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial (Lancet) | <a rel="nofollow" target="blank" href="https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(21)00448-4/fulltext">https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(21)00448-4/fulltext</a><br /><br />Who We Are (Together Trial) | <a rel="nofollow" target="blank" href="https://www.togethertrial.com/who-we-are">https://www.togethertrial.com/who-we-are</a><br /><br />The Sigma-1 Receptor in Cellular Stress Signaling (Frontiers in Neuroscience) | <a rel="nofollow" target="blank" href="https://www.frontiersin.org/articles/10.3389/fnins.2019.00733/full">https://www.frontiersin.org/articles/10.3389/fnins.2019.00733/full</a><br /><br /><br />All coronavirus updates are at MedCram.com (including more discussion on the COVID delta variant, fluvoxamine maleate, serotonin syndrome, and more).<br /><br /><br />SUBSCRIBE TO THE MEDCRAM YOUTUBE CHANNEL:<br /><br /><a rel="nofollow" target="blank" href="https://www.youtube.com/user/MEDCRAMvideos?sub_confirmation=1">https://www.youtube.com/user/MEDCRAMvideos?sub_confirmation=1</a><br />Get notified of new videos by hitting the bell icon<br /><br />MEDCRAM WORKS WITH MEDICAL PROGRAMS AND HOSPITALS:<br /><br />MedCram offers group discounts for students and medical programs, hospitals, and other institutions. Contact us at customers@medcram.com if you are interested.<br /><br /><br />MEDIA CONTACT: <br /><br />Media Contact: customers@medcram.com<br />Media contact info: <a rel="nofollow" target="blank" href="https://www.medcram.com/pages/media-contact">https://www.medcram.com/pages/media-contact</a><br /><br />Video Produced by Kyle Allred<br /><br /><br />FOLLOW US ON SOCIAL MEDIA:<br /><br /><a rel="nofollow" target="blank" href="https://www.facebook.com/MedCram">https://www.facebook.com/MedCram</a><br /><a rel="nofollow" target="blank" href="https://twitter.com/MedCramVideos">https://twitter.com/MedCramVideos</a><br /><a rel="nofollow" target="blank" href="https://www.instagram.com/medcram">https://www.instagram.com/medcram</a><br /><br /><br />DISCLAIMER:<br /><br />MedCram medical videos are for medical education and exam preparation, and NOT intended to replace recommendations from your doctor.<br /><br />#COVID19 #SARSCoV2 #Coronavirus{% endraw %}
